Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Repisodic
AddedFeb 16, 2024
UpdatedJun 18, 2026
Repisodic

Repisodic

Seed

Repisodic: A Health IT platform simplifying the search for optimal post-acute care.

HQ
Philadelphia, PA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Repisodic, founded with the mission to streamline post-acute care, is a health IT platform designed to assist patients and healthcare providers in finding optimal care solutions. The platform offers an easy-to-implement EHR add-on that automates provider list building, enhances patient and caretaker engagement, and optimizes the discharge process at scale. Repisodic's core services focus on improving the efficiency and effectiveness of healthcare referrals, ensuring that every patient receives the best possible post-acute care.

Notable figures affiliated with Repisodic include healthcare professionals and IT experts who have contributed to its development and success. The company has garnered positive feedback from users, highlighting its impact on improving discharge management and patient outcomes. Through its innovative approach, Repisodic has made significant strides in the healthcare IT sector, enhancing the referral system and overall patient care experience.

Repisodic - Similar Companies

Sequentia logo

Sequentia

ReferralMD logo

ReferralMD

getreferralmd.com

Fetch MD logo

Fetch MD

Passage Health logo

Passage Health

passagehealth.com

Post Acute Analytics logo

Post Acute Analytics

paanalytics.com

Behave Health logo

Behave Health

behavehealth.com

Emissary Health logo

Emissary Health

OUTRO logo

OUTRO

outro.com

H1 logo

H1

h1.co

Vispa logo

Vispa

vispaflow.com

eternalHealth logo

eternalHealth

eternalhealth.com

OtisHealth logo

OtisHealth

otishealth.net

Impiricus logo

Impiricus

impiricus.com

Recovery Platform logo

Recovery Platform

Healthie logo

Healthie

gethealthie.com

Repisodic - Quick Facts

Who are Repisodic's competitors?

Companies similar to Repisodic include Sequentia, ReferralMD, Fetch MD and Passage Health.

When was Repisodic founded?

Repisodic was founded in 2017.

Where is Repisodic's headquarters located?

Repisodic's headquarters is located in Philadelphia, PA, US.

When was Repisodic's last funding round?

Repisodic's most recent funding round was for $50k (USD) in February 2021.

How much has Repisodic raised to-date?

As of Feb 18, 2021, Repisodic has raised a total of $1.8M (USD).

How many employees does Repisodic have?

Repisodic has 11 employees as of Feb 5, 2024.

Repisodic - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Healthcare Software
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals
  • 8080Home Health Care Services
  • 8082Home Health Care Services